Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Finished Goods (2016 - 2025)

Historic Finished Goods for INVO Fertility (IVF) over the last 17 years, with Q3 2025 value amounting to $138148.0.

  • INVO Fertility's Finished Goods fell 2651.78% to $138148.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $138148.0, marking a year-over-year decrease of 2651.78%. This contributed to the annual value of $166227.0 for FY2024, which is 2122.99% down from last year.
  • INVO Fertility's Finished Goods amounted to $138148.0 in Q3 2025, which was down 2651.78% from $161110.0 recorded in Q2 2025.
  • In the past 5 years, INVO Fertility's Finished Goods ranged from a high of $222740.0 in Q3 2021 and a low of $138148.0 during Q3 2025
  • For the 5-year period, INVO Fertility's Finished Goods averaged around $195340.4, with its median value being $196586.0 (2024).
  • Per our database at Business Quant, INVO Fertility's Finished Goods surged by 10457.29% in 2021 and then plummeted by 2651.78% in 2025.
  • INVO Fertility's Finished Goods (Quarter) stood at $220168.0 in 2021, then dropped by 11.49% to $194879.0 in 2022, then increased by 8.29% to $211028.0 in 2023, then decreased by 21.23% to $166227.0 in 2024, then dropped by 16.89% to $138148.0 in 2025.
  • Its Finished Goods was $138148.0 in Q3 2025, compared to $161110.0 in Q2 2025 and $163798.0 in Q1 2025.